To further assess IL-33 bioactivity, we administered SLE NET-cleaved or unprocessed (fl)IL-33 to cultures of pDCs, which were stimulated with the TLR-9 ligand CpG-A. The gene discussed is TLR9; the disease is systemic lupus erythematosus.